ReviewFrontiers in medicine2026

PSMA-targeted radioligand therapy with beta emitters in prostate cancer: current evidence, emerging indications, combination strategies, and future directions.

Hiba Noamen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.